Primary Record
Crenolanib
- In stock
- 7,552 g
- Purity
- 98.1 %
- CAS
- 670220-88-9
Compound Identifiers & Properties
- CAS
- 670220-88-9
- PubChem CID
- 10366136
- SMILES
- CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4
- Canonical SMILES
- CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
Names & Synonyms
- Crenolanib
- 670220-88-9
- Crenolanib (CP-868596)
- crenolanibum
- Plarotinib
- Crenolanib [USAN]
- ARO-002
- Crenolanib (USAN)
- CP-868596
- Crenolanib [USAN:INN]
- LQF7I567TQ
- UNII-LQF7I567TQ
- CRENOLANIB [INN]
- ARO 002
- RefChem:579405
- MFCD21609260
- cc-84
- D02AYJ
- D0J1GR
- Crenolanib, CP868569
- Crenolanib,CP-868596
- CP 868596
- CP-868596 (Crenolanib)
- C26H29N5O2
- CRENOLANIB [WHO-DD]
- CP-868,596
- Crenolanib(CP-868596)
- MLS006010956
- CHEBI:145365
- DTXSID50985873
- Crenolanib - CP-868569
- GTPL7882
- orb1305178
- SCHEMBL2730601
- CHEMBL2105728
- CP-868596 (Crenolanib)?
- SCHEMBL29350134
- SCHEMBL29352568
- SCHEMBL30002138
- CP-868569
- EX-A215
- PDGFR Inhibitor CP-868596
- DYNHJHQFHQTFTP-UHFFFAOYSA-N
- BDBM185149
- CP868569
- DTXCID101413063
- GLXC-90124
- HMS3656F19
- AOB87312
- BCP02384
- ZINC3820043
- ABP000963
- CP-868
- NSC763526
- NSC800079
- s2730
- AKOS026750597
- ACN-031571
- BCP9000551
- CCG-264988
- CS-0566
- DB11832
- FC29756
- NSC-763526
- NSC-800079
- RL04552
- SB16603
- SDCCGSBI-0654437.P001
- CID10366136
- NCGC00346658-01
- NCGC00346658-09
- AC-32071
- AS-57698
- BC261910
- CP868596
- DA-62500
- HY-13223
- SMR004702760
- SY237889
- 1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine
- AB0008010
- A8307
- CP-868569)
- FT-0665221
- NS00069320
- SW218293-2
- X7517
- J3.198.440H
- 1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine
- A11052
- D10102
- W-5851
- 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
- A857825
- Q5184160
- 1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine
- BRD-K22127577-001-02-9
- BRD-K22127577-001-03-7
- B0084-456228
- 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine
- 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1H-1,3-benzodiazol-1-yl}quinolin-8-yl)piperidin-4-amine
- CP-868569, 670220-88-9
- CP-868596;CP 868596;CP868596;ARO 002
- [1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine
- 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine.
- (1-(2-(5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl)quinolin-8-yl)piperidin-4-yl)amine
- 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]-8-quinolyl]piperidin-4-amine
- 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzoimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
- 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-1,3-benzodiazol-1-yl)quinolin-8-yl)piperidin-4-amine
- 1-(2-(5-((3-METHYLOXETAN-3-YL)METHOXY)-1H-BENZIMIDAZOL-1-YL)QUINOLIN-8-YL)PIPERIDIN-4-AMINE
- 1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-1,3-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine
- 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine
- 1-[2-[5-[(3-Methyloxetane-3-yl)methoxy]-1H-benzoimidazole-1-yl]-8-quinolinyl]piperidine-4-amine
- 1-{2-[5-(3-Methyl-oxetan-3-ylmethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine
- 4-PIPERIDINAMINE, 1-(2-(5-((3-METHYL-3-OXETANYL)METHOXY)-1H-BENZIMIDAZOL-1-YL)-8-QUINOLINYL)-
- 4-Piperidinamine, 1-(2-(5-((3-methyl-3-oxetanyl)methoxy)-1Hbenzimidazol-1-yl)-8-quinolinyl)-
- 4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-
- 6T2